Placental transfer and metabolism: an overview of the experimental models utilizing human placental tissue
- PMID: 22960472
- DOI: 10.1016/j.tiv.2012.08.027
Placental transfer and metabolism: an overview of the experimental models utilizing human placental tissue
Abstract
Over the decades several ex vivo and in vitro models which utilize delivered human placenta have been developed to study various placental functions. The use of models originating from human placenta to study transplacental transfer and related mechanisms is an attractive option because human placenta is relatively easily available for experimental studies. After delivery placenta has served its purpose and is usually disposed of. The purpose of this review is to give an overview of the use of human placental models for the studies on human placental transfer and related mechanisms such as transporter functions and xenobiotic metabolism. Human placental perfusion, the most commonly used continuous cell lines, primary cells and tissue culture, as well as subcellular fractions are briefly introduced and their major advantages and disadvantages are discussed.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Experimental methods to study human transplacental exposure to genotoxic agents.Mutat Res. 2006 Sep 28;608(2):129-35. doi: 10.1016/j.mrgentox.2006.02.014. Epub 2006 Jul 20. Mutat Res. 2006. PMID: 16857420
-
The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies.Drug Metab Dispos. 2010 Oct;38(10):1623-35. doi: 10.1124/dmd.110.033571. Epub 2010 Jul 6. Drug Metab Dispos. 2010. PMID: 20606001 Review.
-
Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta.Placenta. 2012 Apr;33(4):252-6. doi: 10.1016/j.placenta.2012.01.006. Epub 2012 Jan 20. Placenta. 2012. PMID: 22264585
-
Human placental perfusion method in the assessment of transplacental passage of antiepileptic drugs.Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):489-94. doi: 10.1016/j.taap.2005.01.042. Toxicol Appl Pharmacol. 2005. PMID: 16023691 Review.
-
[Placental transfer of drugs].Therapie. 2014 Jan-Feb;69(1):3-11. doi: 10.2515/therapie/2014002. Epub 2014 Apr 4. Therapie. 2014. PMID: 24698183 French.
Cited by
-
Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability.Pharm Res. 2024 Mar;41(3):493-500. doi: 10.1007/s11095-024-03675-5. Epub 2024 Feb 9. Pharm Res. 2024. PMID: 38337105
-
Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy.Front Pharmacol. 2023 Aug 17;14:1241815. doi: 10.3389/fphar.2023.1241815. eCollection 2023. Front Pharmacol. 2023. PMID: 37663251 Free PMC article.
-
P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses.Front Pharmacol. 2023 May 4;14:1182571. doi: 10.3389/fphar.2023.1182571. eCollection 2023. Front Pharmacol. 2023. PMID: 37214474 Free PMC article. No abstract available.
-
Transplacental passage of hyperforin, hypericin, and valerenic acid.Front Pharmacol. 2023 Mar 31;14:1123194. doi: 10.3389/fphar.2023.1123194. eCollection 2023. Front Pharmacol. 2023. PMID: 37063288 Free PMC article.
-
Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure.Front Pharmacol. 2023 Mar 23;14:1111601. doi: 10.3389/fphar.2023.1111601. eCollection 2023. Front Pharmacol. 2023. PMID: 37033628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
